We are live on ! Find out more
SLXP

SALIX PHARMACEUTICALS LTD DEL
SLXP

Delisted

SLXP was delisted on the 31st of March, 2015.

Back to rankings

1 hedge funds and large institutions have $52K invested in SALIX PHARMACEUTICALS LTD DEL in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 297 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 298 → 1 (-297)

100% less funds holding in top 10

Funds holding in top 10: 47 → 0 (-47)

100% less capital invested

Capital invested by funds: $10.8B → $52K (-$10.8B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 297

Holders
1
Holders Change
-297
Holders Change %
-99.66%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-47
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
297
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PC
Paulson & Co
New York
-$950M
2
PCM
Pentwater Capital Management
Florida
-$652M
3
State Street
State Street
Massachusetts
-$376M
4
YCMGA
York Capital Management Global Advisors
New York
-$327M
5
BIT
BlackRock Institutional Trust
California
-$317M
Name Holding Trade Value Shares
Change 		Change in
Stake
WCMNY
151
Westchester Capital Management (New York)
New York
– -$5.6M -32,400 Closed
VCAM
152
Valentine Capital Asset Management
California
– -$5.56M -32,200 Closed
KBC Group
153
KBC Group
Belgium
– -$5.55M -32,127 Closed
BCM
154
Bluefin Capital Management
New York
– -$5.37M -31,064 Closed
KM
155
KS Management
New York
– -$5.18M -30,000 Closed
SOMRS
156
State of Michigan Retirement System
Michigan
– -$4.99M -28,900 Closed
PCM
157
Prelude Capital Management
New York
– -$4.94M -28,607 Closed
Canada Pension Plan Investment Board
158
Canada Pension Plan Investment Board
Ontario, Canada
– -$4.94M -28,600 Closed
LI
159
LMCG Investments
Massachusetts
– -$4.92M -28,490 Closed
N
160
Nuveen
North Carolina
– -$4.47M -25,843 Closed
CCM
161
Chicago Capital Management
Illinois
– -$4.45M -25,700 Closed
MSA
162
Mason Street Advisors
Wisconsin
– -$4.43M -25,665 Closed
OPPM
163
Opus Point Partners Management
New York
– -$4.15M -24,000 Closed
OPERF
164
Oregon Public Employees Retirement Fund
Oregon
– -$4.04M -23,400 Closed
TI
165
Telemetry Investments
New York
– -$3.99M -23,100 Closed
CCM
166
Clovis Capital Management
New York
– -$3.98M -23,000 Closed
Ohio Public Employees Retirement System (OPERS)
167
Ohio Public Employees Retirement System (OPERS)
Ohio
– -$3.91M -22,610 Closed
JAM
168
JW Asset Management
Florida
– -$3.82M -22,096 Closed
KAM
169
Kassirer Asset Management
Ontario, Canada
– -$3.77M -21,800 Closed
LMGAM
170
Liberty Mutual Group Asset Management
Massachusetts
– -$3.74M -21,627 Closed
Fifth Third Bancorp
171
Fifth Third Bancorp
Ohio
– -$3.59M -20,789 Closed
LCM
172
Laurion Capital Management
New York
– -$3.52M -20,395 Closed
RCG
173
Ruane, Cunniff & Goldfarb
New York
– -$3.46M -20,000 Closed
HSBC Holdings
174
HSBC Holdings
United Kingdom
– -$3.38M -19,583 Closed
FAF
175
Fjarde Ap-fonden
Sweden
– -$3.35M -19,409 Closed
5 6
7
8 9

SLXP Hedge Fund Activity: Q2 2015 in Review

1 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in SALIX PHARMACEUTICALS LTD DEL (SLXP) for Q2 2015, worth a combined $52K — down 100% from $10.8B a quarter earlier.

Sellers outnumbered buyers: 297 funds closed out of SLXP and 0 opened new positions — a net loss of 297 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Paulson & Co, exiting entirely with an estimated $950M sold.

  • 1 institutional investor held SALIX PHARMACEUTICALS LTD DEL (SLXP) as of Q2 2015, down from 298 in Q1 2015.
  • Funds reported $52K of SALIX PHARMACEUTICALS LTD DEL stock for Q2 2015, down 100% quarter-over-quarter.
  • 0 funds opened new SALIX PHARMACEUTICALS LTD DEL positions in Q2 2015 and 297 closed out, a net change of -297 holders.
  • The largest SALIX PHARMACEUTICALS LTD DEL seller in Q2 2015 was Paulson & Co, an estimated $950M sold.

Based on aggregated 13F filings for Q2 2015.